Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway.
| Autor: | Qi Wei, Yuan Ren, Xia Zheng, Sufang Yang, Tingting Lu, Hongyao Ji, Haiqing Hua, Kuizhong Shan |
|---|---|
| Zdroj: | Bioengineered; 2022, Vol. 13 Issue 5, p13919-13928, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|